Article
ANP32A-mediated histone 3 K27 acetylation is essential for sotorasib activity in KRAS-mutant non-small cell lung cancer.
The Journal of biological chemistry - 1 Feb 2026
Pan Kailing, Dang Mingjing, Xu Bo, Huang Zan, Chen Xianguo
Abstract excerpt
Drug resistance is a major challenge for the target therapy of KRAS-mutant non-small cell lung cancer (NSCLC). Here, we observe that ANP32A is tightly associated with KRAS-mutant NSCLC and serves as an unfavorable prognosis factor. ANP32A deficiency impaired cell proliferation, migration, invasion, and cell cycle progression and induced sotorasib (Sot) resistance in KRAS-mutant NSCLC cells, which were reversed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
